ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $92,092,000 | +127805.6% | 34,276 | +91.1% | 0.00% | 0.0% |
Q2 2022 | $72,000 | -10.0% | 17,938 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $80,000 | +19.4% | 17,938 | +6.7% | 0.00% | 0.0% |
Q4 2021 | $67,000 | -39.6% | 16,809 | +33.4% | 0.00% | 0.0% |
Q3 2021 | $111,000 | -22.4% | 12,597 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $143,000 | -2.7% | 12,597 | +1.9% | 0.00% | 0.0% |
Q1 2021 | $147,000 | +8.9% | 12,367 | -37.4% | 0.00% | 0.0% |
Q4 2020 | $135,000 | – | 19,767 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |